Milad Alucozai Overview
- Investor Type
-
Angel
- Status
-
Active
- Investments
-
38
- Portfolio
-
28
- Exits
-
8
Milad Alucozai General Information
Description
Dr. Milad Alucozai serves as General Partner at Pamir Ventures. He most recently served as Head of Biotechnology and Deep Technology at BoxOne Ventures. He is a Co-Founder & serves as Board Member at Revalia Bio. He previously served as Venture Partner at Entrepreneur First, Advisor at Old Silver VC and Lifeomic, Entrepreneur-in-Residence supporting ARPA-H grants, and on the founding team of Corstem. Dr. Alucozai is a scientist, startup founder, and investor with more than two decades of experience in deep technology, life sciences, biotechnology, healthcare, and technology commercialization. His experience includes working with companies from founding through IPO or M&A, including Numerate and Absci, as well as serving as an External Advisor to AstraZeneca, a Board Observer at Talus Bioscience and CytoTronics, an Advisor at Mykonos, a Visiting Scholar in Healthcare Engineering at the Regenstrief Center, and a mentor through the Creative Destruction Lab and Harvard University iLabs. Dr. Alucozai previously served on the board of Mekonos and as a Board Observer at CytoTronics. Dr. Alucozai holds a BS in Neuroscience from Purdue University's Honors Program, a Master's in Immunology from National University of Ireland, and a PhD from Indiana University. He served as Board Member at Seqera.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- San Francisco, CA
- United States
Milad Alucozai Investments (38)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Coding Bio | 05-Sep-2023 | Seed Round | Drug Discovery | Generating Revenue | ||
| Future Fields | 22-Feb-2023 | Biotechnology | Generating Revenue | |||
| Phycobloom | 20-Jan-2023 | Other Energy | Generating Revenue | |||
| GEn1E Lifesciences | 21-Dec-2022 | Biotechnology | Clinical Trials - Phase 2 | |||
| Lobby Studio | 28-Oct-2022 | Business/Productivity Software | Out of Business | |||
| Arpeggio | 01-Aug-2022 | Drug Discovery | Out of Business | |||
| Endpoint Health | 13-Jun-2022 | Drug Discovery | Pre-Clinical Trials | |||
| CytoTronics | 28-Apr-2022 | Discovery Tools (Healthcare) | Generating Revenue | |||
| OMx Personal Health Analytics | 11-Apr-2022 | Later Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| Oath Care | 09-Feb-2022 | Early Stage VC | Other Healthcare Services | Out of Business |
Milad Alucozai Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Arpeggio | 22-Jul-2026 | Out of Business | |
| CytoTronics | 22-Jan-2026 | ||
| Lobby Studio | 19-Dec-2024 | ||
| Oath Care | 13-May-2024 | ||
| Notable Labs | 16-Oct-2023 | ||
| Juno Diagnostics | 31-Jul-2023 | ||
| Volumetric (Biotechnology) | 01-Dec-2021 | Merger/Acquisition | |
| Mekonos | Out of Business |
Milad Alucozai Investments by Industry, Year, and Region
Milad Alucozai Co-Investors (110)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BoxOne Ventures | 5 |
|
|
||
| Builders VC |
|
|
|||
| Khosla Ventures |
|
|
|||
| Matthew De Silva |
|
|
|||
| The Venture Collective |
|
|
Milad Alucozai FAQs
-
Who is Milad Alucozai?
Milad Alucozai is an angel Investor who has made 38 investments.
-
What kind of investor is Milad Alucozai?
Milad Alucozai is an angel investor.
-
What does Milad Alucozai do?
As an angel investor, Milad Alucozai invests personal money into promising companies, typically in exchange for equity.
-
What has Milad Alucozai invested in?
Milad Alucozai has made numerous investments in companies like Coding Bio, Future Fields, and Phycobloom within the Drug Discovery, Biotechnology, and Energy industries.
-
What has Milad Alucozai invested in recently?
Milad Alucozai's latest investment was on 05-Sep-2023 in Coding Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process